6 June 2023FeaturesPatentsMuireann Bolger

UPC: Sanofi v Amgen lands front of queue at new court

The Unified Patent Court (UPC) may be less than a week old but it is already set to be the latest stage for the long-running dispute between Sanofi and Amgen concerning antibody patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

UPC: The ‘sharp sword’ of global patent litigation

15 August 2023 After gaining momentum, are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.

Patents

UPC announces late changes to opt-out functionality

10 March 2023 Unified Patent Court temporarily removes some functionality from opt-out system for ‘privacy and security’ reasons | New guidance also given on registration of representatives.

Patents

Breaking: UPC postponement 'the right thing to do'

5 December 2022 Sunrise period extended over concerns about access to court’s case management system | New period and start date announced by Klaus Grabinski and Johannes Karcher | Full details of new timings.

UK-India trade deal is ‘missed opportunity’, say industry bodies

SEPs now searchable on WIPO’s global patent database

'Nothing can stand in the way of our work': Ukraine resumes IP system

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Apple must pay Optis $700m-the biggest patent award in UK history

Wouter Pors leaves Bird & Bird for boutique Dutch firm

US-China tariffs: What hope is there for IP rightsholders?

UPC: Sanofi v Amgen lands front of queue at new court

More on this story

Editor's picks

Editor's picks

More articles